{"Anti-programmed": [0], "cell": [1], "death": [2], "protein": [3], "1": [4], "(PD-1)": [5], "therapy": [6], "provides": [7], "long-term": [8], "clinical": [9, 47, 74], "benefits": [10], "to": [11, 36, 98, 103], "patients": [12, 64], "with": [13, 23, 61, 65, 101], "advanced": [14], "melanoma.": [15, 67], "The": [16], "composition": [17], "of": [18, 54, 78, 92], "the": [19, 43, 50], "gut": [20, 44], "microbiota": [21, 57, 86], "correlates": [22], "anti-PD-1": [24, 37, 62], "efficacy": [25, 53], "in": [26, 63, 76], "preclinical": [27], "models": [28], "and": [29, 52, 81, 84], "cancer": [30], "patients.": [31], "To": [32], "investigate": [33], "whether": [34], "resistance": [35], "can": [38], "be": [39, 99], "overcome": [40], "by": [41], "changing": [42], "microbiota,": [45], "this": [46], "trial": [48], "evaluated": [49], "safety": [51], "responder-derived": [55], "fecal": [56], "transplantation": [58], "(FMT)": [59], "together": [60], "PD-1-refractory": [66], "This": [68], "combination": [69], "was": [70], "well": [71], "tolerated,": [72], "provided": [73], "benefit": [75], "6": [77], "15": [79], "patients,": [80], "induced": [82], "rapid": [83], "durable": [85], "perturbation.": [87], "Responders": [88], "exhibited": [89], "increased": [90, 105], "abundance": [91], "taxa": [93], "that": [94], "were": [95], "previously": [96], "shown": [97], "associated": [100], "response": [102], "anti-PD-1,": [104], "CD8": [106]}